St. Jude partnership with the WHO – A new, 5-year, $15 million collaboration between St. Jude Children’s Research Hospital and the World Health Organization (WHO) aims to transform cancer care worldwide.
Integration of Bereaved Parents – St. Jude leads the world in the integration of bereaved parents into Patient Family-Centered Care, and works to share their methods with the world.
CureSearch Researchers Offer Hope to Children with Brain Cancer – Dr. Richard Gilbertson of the University of Cambridge, featured in the article, was formerly head of the Comprehensive Cancer Center at St. Jude.
Accelerating Progress Through Global Collaboration – Clinical trial SJMB12, headed by Dr. Amar Gajjar (Sam’s St. Jude oncologist), focuses on medulloblastoma. St. Jude is driving a collaboration with 20 other hospitals around the world.
St. Jude Proton Therapy – Learn more about the use of proton radiation therapy at St. Jude
St. Jude Research on CNS-PNET Tumors – Discovery of likely subtypes of rare childhood brain tumor signals diagnostic advance
St. Jude Red Frog Events Proton Therapy Center – St. Jude opens the world’s first proton therapy center dedicated solely to treating children.
New Reason for Hope – A Huffington Post article about research being conducted by Sam’s oncologist Dr. Amar Gajjar of St. Jude Children’s Research Hospital
Cancer Cures: Hidden in Plain Sight? – An article by St. Jude Children’s Research Hospital on the investigation of drugs used to treat cancer in adults as a treatment option for medulloblastoma
Pediatric Cancer Genome Project – An article on the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project’s findings on medulloblastoma
Medulloblastoma Clinical Trial – SJMB12: A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Medulloblastoma Research – A Cancer.net article on the lastest research on medulloblastoma and a guide to futher information.
Potential for use of anti-depressants to treat Medulloblastoma – Information on the results of a study indicating current anti-depressant medication may target a pathway used by medulloblastoma